Effect of levodopa and entacapone treatment on plasma homocysteine level in Parkinson's disease. Pilot study.

被引：0
|
作者：
Nevrly, M. [1 ]
Ressner, P. [1 ]
Nestrasil, I. [1 ]
Vranova, H. [1 ]
Herzig, R. [1 ]
Kanovsky, P. [1 ]
机构：
[1] Palacky Univ, Dept Neurol, Univ Hosp, CR-77147 Olomouc, Czech Republic
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] Effect of levodopa and entacapone treatment on plasma homocysteine level in Parkinson disease. A pilot study
    Nevrly, M.
    Vranova, H.
    Ressner, P.
    Nestrasil, I.
    Kanovsky, P.
    MOVEMENT DISORDERS, 2006, 21 : S545 - S545
  • [2] Plasma homocysteine levels in Parkinson's disease patients - the effect of levodopa and entacapone treatment. Pilot study
    Nevrly, M.
    Ressner, P.
    Nestrasil, I.
    Vranova, H.
    Herzig, R.
    Kanovsky, P.
    JOURNAL OF NEUROLOGY, 2006, 253 : 93 - 94
  • [3] Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients
    Nevrly, M.
    Kanovsky, P.
    Vranova, H.
    Langova, K.
    Hlustik, P.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (06) : 477 - 478
  • [4] Effect of entacapone on plasma homocysteine levels in Parkinson’s disease patients
    Martin Nevrly
    Petr Kanovsky
    Hana Vranova
    Katerina Langova
    Petr Hlustik
    Neurological Sciences, 2010, 31 : 565 - 569
  • [5] Effect of entacapone on plasma homocysteine levels in Parkinson's disease patients
    Nevrly, Martin
    Kanovsky, Petr
    Vranova, Hana
    Langova, Katerina
    Hlustik, Petr
    NEUROLOGICAL SCIENCES, 2010, 31 (05) : 565 - 569
  • [6] The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease
    Grofik, Milan
    Sivak, Stefan
    Nosal, Vladimir
    Koprusakova, Monika Turcanova
    Michalik, Jozef
    Cierny, Daniel
    Tatarkova, Zuzana
    Kurca, Egon
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 392 : 28 - 31
  • [7] Levodopa for the Treatment of Parkinson's Disease.
    LeWitt, Peter A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2468 - 2476
  • [8] Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients
    Valkovic, P
    Benetin, J
    Blazicek, P
    Valkovicová, L
    Gmitterová, K
    Kukumberg, P
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) : 253 - 256
  • [9] Entacapone significantly decreases elevated plasma homocysteine levels in levodopa-treated Parkinson's disease patients
    Nissinen, H
    Ellmen, J
    Vahteristo, M
    MOVEMENT DISORDERS, 2005, 20 : S94 - S94
  • [10] Peripheral neuropathy and plasma homocysteine level in Parkinson's disease patients: A pilot study
    Nevrly, M.
    Vranova, H.
    Chovancova, Z.
    Nestrasil, L.
    Otruba, P.
    Dufeck, J.
    Kanovsky, P.
    MOVEMENT DISORDERS, 2007, 22 : S32 - S32
12345